Medical costs reduced over two years for privately insured adults with prediabetes participating in the program<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b>
\n<\/b><\/p>\n
TUESDAY, Jan. 7, 2025 (HealthDay News) — Participants with prediabetes enrolled in the National Diabetes Prevention Program (NDPP) have a reduction in direct medical costs over two years, according to a study published online Nov. 20 in Diabetes Care<\/em>.<\/p>\n Shihchen Kuo, from the University of Michigan in Ann Arbor, and colleagues evaluated the real-world cost-effectiveness of the NDPP. The analysis included individual-level health insurance claims and survey data for 5,948 adults with prediabetes who enrolled (575 individuals) or did not enroll (5,373 individuals) in the NDPP.<\/p>\n The researchers found that compared with nonenrollees, each NDPP enrollee had an average reduction of $4,552 in two-year total direct medical costs. Hospitalizations, outpatient visits, and emergency room visits drove cost savings. There were no significant differences between the groups for EuroQol 5-Dimension 5-level questionnaire utility scores or quality-adjusted life-years (QALYs) gained over two years. Enrollment in the NDPP had an 88 percent probability of saving money and 84 percent probability of being cost-effective at a willingness-to-pay threshold of $100,000\/QALY gained over two years.<\/p>\n “If delivered to a larger prediabetes population with longer-term follow-up, the NDPP could potentially reduce health care costs and improve QALYs for millions of American adults with prediabetes,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n